Get the Stockscreener App
7.32
6.51%
-0.51
After Hours:
7.18
-0.14
-1.91%
Biodesix Inc stock is traded at $7.32, with a volume of 26,378.
It is down -6.51% in the last 24 hours and down -29.83% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$7.83
Open:
$7.85
24h Volume:
26,378
Relative Volume:
0.21
Market Cap:
$62.64M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-11.26
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-5.43%
1M Performance:
-29.83%
6M Performance:
-35.79%
1Y Performance:
-78.47%
1-Day Range:
$7.26
$7.9722
1-Week Range:
$7.11
$8.20
52-Week Range:
$3.436
$34.40
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
7.32 | 62.64M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - 富途牛牛
Biodesix Implements Reverse Stock Split on September 15 - MSN
What recovery options are there for Biodesix Inc.Quarterly Portfolio Report & Smart Swing Trading Techniques - newser.com
What the charts say about Biodesix Inc. todayJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
News impact scoring models applied to Biodesix Inc.Weekly Trend Summary & Target Return Focused Picks - newser.com
Is Biodesix Inc. stock bottoming out2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Biodesix's (BDSX) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
How to read the order book for Biodesix Inc.Layoff News & Scalable Portfolio Growth Methods - newser.com
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biodesix Unveils October Lung Health Events in Colorado - GlobeNewswire
3 October Lung Health Events: Biodesix Partners with APAPP, Go2 & American Lung Association in Colorado - Stock Titan
Why retail investors pile into Biodesix Inc. stockEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com
Market reaction to Biodesix Inc.’s recent newsEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
What Fibonacci levels say about Biodesix Inc. reboundWeekly Trade Analysis & Verified Momentum Watchlists - newser.com
Trend analysis for Biodesix Inc. this weekCPI Data & Fast Gaining Stock Strategy Reports - newser.com
Can technical indicators confirm Biodesix Inc.’s reversalTrade Ideas & Weekly Top Gainers Trade List - newser.com
Understanding Biodesix Inc.’s price movementAnalyst Upgrade & Smart Investment Allocation Insights - newser.com
Biodesix Regains Nasdaq Compliance with Bid Price - TipRanks
What MACD signals say about Biodesix Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
Biodesix (BDSX) Price Target Increased by 1,900.00% to 35.70 - Nasdaq
What analysts say about Biodesix Inc stockEconomic Indicators Overview & Rapid Wealth Building Tips - earlytimes.in
What drives Biodesix Inc stock priceMarket Correction Analysis & Free Discover Breakout Stocks Early - earlytimes.in
Will Biodesix Inc. stock reach all time highs in 2025Inflation Watch & AI Enhanced Trading Signals - The British Mountaineering Council
Director’s Bold Move: Massive Biodesix Stock Purchase Unveiled! - TipRanks
Hedge Fund and Insider Trading News: Warren Buffett, D. E. Shaw, Walleye Capital, Greenlight Capital, Citadel Investment Group, Elliott Management, Cassava Sciences Inc (SAVA), Biodesix Inc (BDSX), and More - Insider Monkey
Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 142,045 Shares - MarketBeat
Schuler buys Biodesix (BDSX) shares worth $999k By Investing.com - Investing.com Nigeria
Schuler buys Biodesix (BDSX) shares worth $999k - Investing.com India
Biodesix (NASDAQ:BDSX) Director Purchases $92,514.68 in Stock - MarketBeat
Biodesix (NASDAQ:BDSX) Director Purchases $18,855.52 in Stock - MarketBeat
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biodesix Inc Stock (BDSX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SCHULER JACK W | Director |
Sep 17 '25 |
Buy |
6.04 |
15,317 |
92,571 |
1,235,644 |
| SCHULER JACK W | Director |
Sep 18 '25 |
Buy |
6.17 |
3,056 |
18,854 |
1,238,700 |
| SCHULER JACK W | Director |
Aug 29 '25 |
Buy |
0.43 |
3,488,372 |
1,500,000 |
24,406,546 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Aug 13 '25 |
Sale |
0.42 |
988 |
411 |
250,794 |
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
| O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
| Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
| Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
| SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
0.17%
2.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):